Krystal Biotech (KRYS) Asset Utilization Ratio (2023 - 2026)

Krystal Biotech (KRYS) has 4 years of Asset Utilization Ratio data on file, last reported at 0.31 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 2.37% year-over-year to 0.31; the trailing twelve-month figure through Mar 2026 stood at 0.31 (down 2.37% YoY), and the FY2025 full-year result was 0.33, up 5.05% from the prior year.
• Asset Utilization Ratio grew to 0.31 in Q1 2026, from 0.3 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.32 in Q2 2025 to a low of 0.01 in Q3 2023.
• A 4-year average of 0.23 and a median of 0.29 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio jumped 2090.62% in 2024 and dropped 2.37% in 2026, its largest moves.
• Tracing KRYS's Asset Utilization Ratio over 4 years: stood at 0.06 in 2023, then soared by 352.3% to 0.29 in 2024, then increased by 6.06% to 0.3 in 2025, then grew by 1.09% to 0.31 in 2026.
• Business Quant data shows KRYS's Asset Utilization Ratio at 0.31 in Q1 2026, 0.3 in Q4 2025, and 0.31 in Q3 2025.